Kelun-Biotech’s Sac-TMT shows breakthrough results in first-line lung cancer trial
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The formulation is backed by over 80 clinical trials and 200 scientific publications
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
India currently hosts more than 10,075 biotech startups
Subscribe To Our Newsletter & Stay Updated